A study to test how kidney problems influence the blood concentrations of efgartigimod

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503992-88-00

Acronym

ARGX-113-2201

Enrollment

Registered

2023-06-20

Start date

2023-07-14

Completion date

2024-06-12

Last updated

2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal impairment

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026